1753 related articles for article (PubMed ID: 16153475)
1. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
2. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
3. Role of budget impact in drug reimbursement decisions.
Cohen JP; Stolk E; Niezen M
J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
[TBL] [Abstract][Full Text] [Related]
4. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
5. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
6. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
Delwel GO; Sprenger MJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of medical technologies.
Seifan A; Shemer J
Isr Med Assoc J; 2005 Feb; 7(2):67-70. PubMed ID: 15729952
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis in a setting of budget constraints--is it equitable?
Ubel PA; DeKay ML; Baron J; Asch DA
N Engl J Med; 1996 May; 334(18):1174-7. PubMed ID: 8602185
[TBL] [Abstract][Full Text] [Related]
9. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
Gafni A; Birch S
Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
[TBL] [Abstract][Full Text] [Related]
10. Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents.
Jahn B; Pfeiffer KP; Theurl E; Tarride JE; Goeree R
Med Decis Making; 2010; 30(1):16-28. PubMed ID: 19789389
[TBL] [Abstract][Full Text] [Related]
11. The Gambia: cost and effectiveness of a mobile maternal health care service, West Kiang.
Fox-Rushby JA
World Health Stat Q; 1995; 48(1):23-7. PubMed ID: 7571706
[TBL] [Abstract][Full Text] [Related]
12. Generalised cost-effectiveness analysis: an aid to decision making in health.
Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
[TBL] [Abstract][Full Text] [Related]
13. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis and formulary decision making in England: findings from research.
Williams IP; Bryan S
Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
[TBL] [Abstract][Full Text] [Related]
15. Health system and equity perspectives in health technology assessment.
Hanvoravongchai P
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
[TBL] [Abstract][Full Text] [Related]
16. The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold.
Birch S; Gafni A
J Health Serv Res Policy; 2006 Jan; 11(1):46-51. PubMed ID: 16378532
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
18. Budgeting in health care systems.
Maynard A
Eff Health Care; 1984; 2(2):41-9. PubMed ID: 10269645
[TBL] [Abstract][Full Text] [Related]
19. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
20. The planning cycle.
Johnson W
J Healthc Inf Manag; 2005; 19(3):56-64. PubMed ID: 16045085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
